Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study

Background Lung adenocarcinoma is a prevalent malignancy. Mutations in the epidermal growth factor receptor (EGFR) have introduced novel prospects for targeted therapies. However, the status of EGFR mutations alone may be insufficient to fully predict treatment outcomes. To this end, the present res...

Descripción completa

Detalles Bibliográficos

Autores principales:	Jiali Li, Shuting Wang, Zhiyong Deng, Lu Zhang, Min Liu, Yunlei Luo, Yunqiu Guo, Pengjie Liu, Chao Liu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	PeerJ Inc. 2026-01-01
Colección:	PeerJ
Materias:	Lung adenocarcinom Serum markers EGFR-TKI Bone metastases Prognostic prediction
Acceso en línea:	https://peerj.com/articles/20537.pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!